Crossmark

Tumor mutational burden as a new biomarker for PD-1 antibody treatment in gastric cancer

Crossref DOI link: https://doi.org/10.1186/s40880-019-0417-1

Published Online: 2019-11-14

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Folprecht, Gunnar
License Information

Text and Data Mining valid from 2019-11-14
More Information

Article History

Received: 29 October 2019

Accepted: 1 November 2019

First Online: 14 November 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The author declares no competing interests.